ARAKODA Trademark

Trademark Overview

On Thursday, November 16, 2017, a trademark application was filed for ARAKODA with the United States Patent and Trademark Office. The USPTO has given the ARAKODA trademark a serial number of 87688137. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, March 23, 2026. This trademark is owned by 60° Pharmaceuticals, LLC. The ARAKODA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical anti-malaria preparations; Pharmaceutical preparations for the prevention of malaria
arakoda

General Information

Serial Number87688137
Word MarkARAKODA
Filing DateThursday, November 16, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 23, 2026
Registration Number5950691
Registration DateTuesday, December 31, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements

Goods and ServicesPharmaceutical anti-malaria preparations; Pharmaceutical preparations for the prevention of malaria

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 30, 2017
Primary Code005
First Use Anywhere DateFriday, September 6, 2019
First Use In Commerce DateFriday, September 6, 2019

Trademark Owner History

Party Name60° Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20036
US
Party Name60° Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20036
US
Party Name60° Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20036
US

Trademark Events

Event DateEvent Description
Monday, November 20, 2017NEW APPLICATION ENTERED
Thursday, November 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 19, 2017ASSIGNED TO EXAMINER
Wednesday, December 20, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 20, 2017NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 26, 2018ASSIGNED TO LIE
Tuesday, January 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 9, 2018SOU TEAS EXTENSION RECEIVED
Friday, November 9, 2018SOU EXTENSION 1 FILED
Friday, November 9, 2018SOU EXTENSION 1 GRANTED
Tuesday, November 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2019SOU TEAS EXTENSION RECEIVED
Friday, March 15, 2019SOU EXTENSION 2 FILED
Friday, March 15, 2019SOU EXTENSION 2 GRANTED
Tuesday, March 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, November 19, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 11, 2019USE AMENDMENT FILED
Tuesday, November 19, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 31, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 29, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, March 23, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 23, 2026REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, March 23, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

arakoda preparations pharmaceutical malaria prevention anti